EpiPen®
- Dr. Steven Horwitz
- Apr 1, 2020
- 1 min read
"In a letter to healthcare professionals from Pfizer and Mylan, the ways in which administration of the emergency treatment may be delayed or prevented are described. These include device failure from spontaneous activation caused by using sideways force to remove the blue safety release or caused by a raised blue safety release, problems related to removing the device from the carrier tube, and user administration errors."
Read more here.
More on EpiPen®:
Comments